Overcoming personal information protection challenges involving real-world data to support public health efforts in China
In the information age, real-world data-based evidence can help extrapolate and supplement data from randomized controlled trials, which can benefit clinical trials and drug development and improve public health decision-making. However, the legitimate use of real-world data in China is limited due...
Main Authors: | Yu Yao, Fei Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1265050/full |
Similar Items
-
Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union
by: Kelly H. Zou, et al.
Published: (2024-08-01) -
The Problem of Trans-Border Information Flows in the Protection of Personal Information
by: Mthuthukisi Malahleka
Published: (2024-08-01) -
Comparative Insights from the EU’s GDPR and China’s PIPL for Advancing Personal Data Protection Legislation
by: Gulbakyt Bolatbekkyzy
Published: (2024-09-01) -
Implementing tokenization in clinical research to expand real-world insights
by: Chelsea Walters, et al.
Published: (2025-02-01) -
Linking clinical trial participants to their U.S. real-world data through tokenization: A practical guide
by: Michael J. Eckrote, et al.
Published: (2024-10-01)